NCT04543552

Brief Summary

As a part of the urodynamic studies, urinary catheterization is inserted to measure residual urine, however, it has shown to be an invasive procedure, cause urinary tract infection, and traumatic experience. Bladder scan has been introduced as an alternative and non-invasive method to measure urine residual in the bladder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 13, 2017

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 10, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2021

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

May 12, 2021

Status Verified

July 1, 2020

Enrollment Period

3.5 years

First QC Date

July 7, 2020

Last Update Submit

May 11, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Scanned bladder volume

    Measurement of the bladder volume

    Immediately after procedure (urodynamics studies)

  • Estimated Post Void Residue

    Estimated PVR

    Immediately after procedure (urodynamics studies)

  • Drainage volume

    Residual urine drained by using a catheter

    Immediately after procedure (urodynamics studies)

Study Arms (1)

Bladder Scan

Subjects who are scheduled to undergo urodynamic studies.

Device: Bladder scan

Interventions

Bladder Scanner, or Biocon-900 is an ultrasonic imaging device that has been developed to measure post-void residual volume of the bladder non-invasively. The images and measurements are obtained by applying a probe onto the abdomen (i.e. bladder). As it scans, the scanner constructs 12 cross-sectional images at 15 degree interval using the reflection signals from urine in the bladder and extracts the position of the bladder wall as well. During urodynamic studies, the bladder scan will measure the infused volume in order to assess difference between the infused and scanned volumes.

Also known as: Bladder Scanner, Biocon-900
Bladder Scan

Eligibility Criteria

Age1 Month - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Subjects who are scheduled to undergo urodynamic studies due to suspected changes in the bladder function or shape.

You may qualify if:

  • Under the age of 6 years old.
  • Urodynamic study is scheduled to due to suspected changes in the bladder function or shape.
  • Those who understand and sign the informed consent form.

You may not qualify if:

  • Subjects with surgical history of the bladder.
  • Constant leaking of the urine due to bladder neck contracture.
  • Any congenital abnormalities that induce changes in the shape of the bladder.
  • Unsuitable to participate in the study at the discretion of the principal investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

Urinary Bladder, NeurogenicUrinary Bladder, UnderactiveUrinary Bladder, Overactive

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsLower Urinary Tract SymptomsUrological Manifestations

Study Officials

  • Kwanjin Park, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2020

First Posted

September 10, 2020

Study Start

November 13, 2017

Primary Completion

April 29, 2021

Study Completion

May 1, 2021

Last Updated

May 12, 2021

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations